Announcement Of A Firm Intention By CFR Pharmaceuticals To Acquire 100% Of The Issued Share Capital Of Adcock Ingram By Way Of A Scheme Of Arrangement
11/18/2013 9:35:59 AM
SANTIAGO, Chile, Nov. 15, 2013 (GLOBE NEWSWIRE) -- CFR Pharmaceuticals S.A. (SSE:CFR), the Chilean multinational emerging markets pharmaceutical company, leader in specialities and prescription medicines, today issued a firm intention announcement ("FIA") to acquire 100% of the issued share capital (excluding the Bophelo Scheme Shares and the Treasury Shares) of Adcock Ingram Holdings Limited ("Adcock Ingram"), the South Africa pharmaceutical company, for a total consideration of approximately US$1.26 billion ("Acquisition"). Terms not defined herein have the meaning attributed to them in the FIA.
Help employers find you! Check out all the jobs and post your resume.
comments powered by